#BEGIN_DRUGCARD DB03931

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C20H27N10O18P3

# Chemical_IUPAC_Name:
{[(2S,3R,4R,5R)-5-(2-amino-6-oxo-6,9-dihydro-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({[({[(2S,3R,4R,5R)-5-(2-amino-6-oxo-6,9-dihydro-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)phosphinic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Diguanosine-5'-Triphosphate

# HET_ID:
GP3

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C20H27N10O18P3/c21-19-25-13-7(15(35)27-19)23-3-29(13)17-11(33)9(31)5(45-17)1-43-49(37,38)47-51(41,42)48-50(39,40)44-2-6-10(32)12(34)18(46-6)30-4-24-8-14(30)26-20(22)28-16(8)36/h3-6,9-12,17-18,31-34H,1-2H2,(H,37,38)(H,39,40)(H,41,42)(H3,21,25,27,35)(H3,22,26,28,36)/t5-,6-,9-,10-,11+,12+,17+,18+/m0/s1

# InChI_Key:
InChIKey=AAXYAFFKOSNMEB-QWYLYUGKSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
3931

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
788.4059

# Molecular_Weight_Mono:
788.071763646

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1CKO

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-0.77

# Predicted_LogS:
-2.2

# Predicted_Water_Solubility:
4.84e+00 g/l

# Primary_Accession_No:
DB03931

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
46936831

# PubChem_Substance_ID:
46507269

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT01633

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
NC1=NC2=C(N=CN2[C@@H]2O[C@@H](CO[P@](O)(=O)OP(O)(=O)O[P@@](O)(=O)OC[C@@H]3O[C@H]([C@H](O)[C@H]3O)N3C=NC4=C3N=C(N)NC4=O)[C@H](O)[C@H]2O)C(=O)N1

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:22:46 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Not Available

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
U42580

# Drug_Target_1_GenBank_ID_Protein:
1131446

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
A103R

# Drug_Target_1_Gene_Sequence:
>993 bp
ATGGTTCCTCCCACAATCAACACCGGCAAAAATATCACTACCGAACGCGCCGTCTTGACG
CTCAACGGTCTGCAAATAAAGCTGCATAAGGTTGTCGGAGAATCTCGCGATGATATCGTT
GCCAAGATGAAAGATCTCGCTATGGACGACCATAAGTTCCCCAGGCTGCCGGGTCCCAAC
CCGGTTAGCATTGAGCGAAAGGACTTTGAAAAATTGAAGCAGAATAAATACGTCGTATCG
GAAAAGACGGATGGTATTCGGTTCATGATGTTTTTCACTCGGGTTTTCGGGTTCAAGGTG
TGTACTATTATTGACCGCGCGATGACTGTATACCTTCTTCCTTTCAAGAACATTCCCCGA
GTTCTATTTCAAGGTTCTATTTTCGATGGAGAGTTGTGCGTTGACATCGTCGAAAAGAAA
TTTGCGTTTGTTCTATTTGACGCCGTCGTGGTGAGTGGTGTTACCGTGAGTCAGATGGAT
CTTGCAAGTCGCTTCTTTGCGATGAAGAGGTCTCTTAAAGAGTTCAAGAATGTTCCCGAG
GATCCCGCCATTCTTCGATACAAAGAATGGATTCCACTCGAGCATCCAACTATCATCAAG
GACCATCTCAAAAAGGCCAATGCTATTTATCATACCGACGGTCTTATCATAATGAGCGTT
GACGAACCTGTTATTTATGGACGGAATTTCAATTTGTTCAAGCTGAAGCCCGGGACCCAC
CATACTATTGACTTCATTATCATGAGCGAAGATGGGACAATCGGCATCTTCGATCCTAAT
TTGAGGAAGAATGTTCCCGTCGGAAAACTTGATGGTTATTACAATAAGGGTTCTATCGTA
GAATGTGGATTCGCTGATGGAACGTGGAAATATATTCAGGGGCGTTCTGACAAAAACCAA
GCAAATGATCGTTTGACATACGAAAAGACACTACTGAACATCGAGGAAAACATTACGATT
GACGAATTGCTTGATTTGTTCAAATGGGAGTGA

# Drug_Target_1_General_Function:
Involved in mRNA guanylyltransferase activity

# Drug_Target_1_General_References:
7676624	Li Y, Lu Z, Burbank DE, Kutish GF, Rock DL, Van Etten JL: Analysis of 43 kb of the Chlorella virus PBCV-1 330-kb genome: map positions 45 to 88. Virology. 1995 Sep 10;212(1):134-50.
9160746	Hakansson K, Doherty AJ, Shuman S, Wigley DB: X-ray crystallography reveals a large conformational change during guanyl transfer by mRNA capping enzymes. Cell. 1997 May 16;89(4):545-53.
9465045	Hakansson K, Wigley DB: Structure of a complex between a cap analogue and mRNA guanylyl transferase demonstrates the structural chemistry of RNA capping. Proc Natl Acad Sci U S A. 1998 Feb 17;95(4):1505-10.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
3311

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
37833

# Drug_Target_1_Name:
mRNA-capping enzyme

# Drug_Target_1_Number_of_Residues:
330

# Drug_Target_1_PDB_ID:
1CKO

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF01331	mRNA_cap_enzyme
PF03919	mRNA_cap_C

# Drug_Target_1_Protein_Sequence:
>mRNA-capping enzyme
MVPPTINTGKNITTERAVLTLNGLQIKLHKVVGESRDDIVAKMKDLAMDDHKFPRLPGPN
PVSIERKDFEKLKQNKYVVSEKTDGIRFMMFFTRVFGFKVCTIIDRAMTVYLLPFKNIPR
VLFQGSIFDGELCVDIVEKKFAFVLFDAVVVSGVTVSQMDLASRFFAMKRSLKEFKNVPE
DPAILRYKEWIPLEHPTIIKDHLKKANAIYHTDGLIIMSVDEPVIYGRNFNLFKLKPGTH
HTIDFIIMSEDGTIGIFDPNLRKNVPVGKLDGYYNKGSIVECGFADGTWKYIQGRSDKNQ
ANDRLTYEKTLLNIEENITIDELLDLFKWE

# Drug_Target_1_Reaction:
GTP + (5')ppPur-mRNA = diphosphate + G(5')pppPur-mRNA

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
mRNA capping. Transfers a GMP cap onto the end of mRNA that terminates with a 5'-diphosphate tail

# Drug_Target_1_SwissProt_ID:
Q84424

# Drug_Target_1_SwissProt_Name:
MCE_PBCV1

# Drug_Target_1_Synonyms:
EC 2.7.7.50
GTP--RNA guanylyltransferase
mRNA guanylyltransferase

# Drug_Target_1_Theoretical_pI:
8.42

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB03931
